September 22, 2015
FDA warns about Avycaz dosing errors
FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and…
Pharmaceuticals, Biotechnology and Life Sciences
FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and…